Molecular Testing of Lung Cancers

Targeted therapies guided by molecular diagnostics have become a standard treatment of lung cancer. Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are currently used as the best predictive biomarkers for EGFR tyrosine kinase inhibitors and ALK i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pathol Transl Med
Hlavní autoři: Shim, Hyo Sup, Choi, Yoon-La, Kim, Lucia, Chang, Sunhee, Kim, Wan-Seop, Roh, Mee Sook, Kim, Tae-Jung, Ha, Seung Yeon, Chung, Jin-Haeng, Jang, Se Jin, Lee, Geon Kook
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society of Pathologists and the Korean Society for Cytopathology 2017
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445209/
https://ncbi.nlm.nih.gov/pubmed/28427247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2017.04.10
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky